1. Micro-transplantation in an elderly patient with very high risk MDS:A case report and literature review
- Author
-
Kangli Wu, Mingsuo Liu, Yajun Wu, Qiulian Luo, Jin Chen, Wanling Xu, Xixi Yang, Piaoru Hong, and Zhigang Qu
- Subjects
Micro-transplantation ,Myelodysplastic syndromes ,Treatment ,Myelosuppression ,Neoplasms. Tumors. Oncology. Including cancer and carcinogens ,RC254-282 - Abstract
Introduction: The prognosis of patients with myelodysplastic syndromes (MDS) (very high risk) is poor.HLA-mismatched allogeneic T-cell infusion which is called micro-transplantation can not only shorten the time of bone marrow suppression, but also improve the treatment response of patients. Case presentation: A 74-year-old woman presented with fatigue and showed pancytopenia on routine blood count. She was diagnosed with MDS (very high risk) after bone marrow examination,then she received 4 cycles of micro-transplantation. The progression-free survival was 22 months and overall survival was 33 months. Discussion: The patient showed good tolerance to micro-transplantation with manageable toxicities and short myelosuppression time.
- Published
- 2024
- Full Text
- View/download PDF